Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Aug 2023 for ABL Diagnostics, €456. Read the official filing
Filing timeline
BuySaleADVANCED BIOLOGICAL LABORATORIES SA Société Anonyme personne morale liée à Valentin Capital Management S.A.
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Positive at T+90
0%
Median T+90
+0.0%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -71.3%Entry €9.70 · Close at T+365 €2.78
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
ADVANCED BIOLOGICAL LABORATORIES SA Société Anonyme personne morale liée à Valentin Capital Management S.A.: trading record in brief
ADVANCED BIOLOGICAL LABORATORIES SA Société Anonyme personne morale liée à Valentin Capital Management S.A. appears in our data through filings on ABL Diagnostics shares, published by AMF. Between 5 June 2023 and 15 August 2023, the trades on record add up to 2 filings.
Purchases make up the whole of the open-market record (2 purchases, €1,336). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 30 August 2023 came the latest disclosure, an open-market purchase for €456 in ABL Diagnostics. Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.
Companies and markets linked to ADVANCED BIOLOGICAL LABORATORIES SA Société Anonyme personne morale liée à Valentin Capital Management S.A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
▲
95 shares@ €4.8034.1% of flowActionEuronext ParisISIN FR001400AHX62023DD925593
Canonical exit: 3 Sept 2023 (T+90)
▲
100 shares@ €8.8065.9% of flowActionEuronext ParisISIN FR001400AHX62023DD925594
Canonical exit: 13 Nov 2023 (T+90)
2 of 2 declarations
